Cytogenetic effects of met-enkephalin (peptid-M) on human lymphocytes (CROSBI ID 81241)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Štambuk, Nikola ; Kopjar, Nevenka ; Šentija, Karmela ; Garaj-Vrhovac, Vera ; Vikić-Topić, Dražen ; Marušić-Della Marina, Branka ; Brinar, Vesna ; Trbojević-Čepe, Milica ; Žarković, Neven ; Ćurković, Božidar ; Babić-Naglić, Đurđa ; Hadžija, Mirko ; Zurak, Niko ; Brzović, Zdravko ; Martinić, Roko ; Štambuk, Vjera ; Konjevoda, Paško ; Ugrinović, Nikola ; Pavlić-Renar, Ivana ; Biđin, Zdenko ; Pokrić, Biserka
engleski
Cytogenetic effects of met-enkephalin (peptid-M) on human lymphocytes
The structure, complementary structure and cytogenetic/proliferative effects of the Met-enkephalin on human peripheral blood lymphocytes were analyzed. Met-enkephalin, i.e. Peptid-M (LUPEX), is a low molecular weight synthetic pentapeptide that corresponds to thymus Met-enkephalin, Its structure was examined by means of NMR spectroscopy. The influence of Met-enkephalin on in vitro normalization of chromosomally aberrant lymphocytes of patients suffering from different immune-mediated diseases, was analyzed by the sensitive cytogenetic tests for screening and detection of genome damages in human lymphocytes. The tests showed that in vitro stimulation of human lymphocytes with the Met-enkephalin led to disappearance of different types of chromosome aberrations, reduction in the number of micronuclei, decrease in the frequency of sister chromatid exchange (SCE) and apoptosis as well as a cytostatic effect on mitosis cycles. They have also confirmed normalization of chromosomally aberrant cell findings in patients suffering from different immune-mediated diseases. These results suggest a possible role of Met-enkephalin (Peptid-M) in immunotherapy of different diseases which involve chromosomal aberrations as well as abnormal cell proliferation and offer new approaches to immunotherapy by the use of Peptid-M. Based on the molecular recognition theory and the SCA method, peptide complementary to Peptid-M was designed, synthesized and denoted Peptide-D. Peptide-D isa calpastatin fragment. Predicted ligand-receptor interaction between both peptides is confirmed by the results showing that Peptide-D blocked the Peptid-M induced lymphocyte proliferation in a dose-dependent manner.
inhibition; kinetics; receptor; cytokine; protein
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kemija, Temeljne medicinske znanosti, Biologija